Early insulin resistance in severe trauma without head injury as outcome predictor? A prospective, monocentric pilot study by Manuela Bonizzoli et al.
Bonizzoli et al. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2012, 20:69
http://www.sjtrem.com/content/20/1/69ORIGINAL RESEARCH Open AccessEarly insulin resistance in severe trauma without
head injury as outcome predictor? A prospective,
monocentric pilot study
Manuela Bonizzoli1, Giovanni Zagli1*, Chiara Lazzeri2, Sara Degl’Innocenti1, Gianfranco Gensini2 and Adriano Peris1Abstract
Background: Hyperglycemia following major trauma is a well know phenomenon related to stress-induced
systemic reaction. Reports on glucose level management in patients with head trauma have been published, but
the development of insulin resistance in trauma patients without head injury has not been extensively studied. The
aim of this study was therefore to investigate the prognostic role of acute insulin-resistance, assessed by the HOMA
model, in patients with severe trauma without head injury.
Methods: All patients consecutively admitted to the Intensive Care Unit (ICU) of a tertiary referral center (Careggi
Teaching Hospital, Florence, IT) for major trauma without head injury (Jan-Dec 2010) were enrolled. Patients with a
previous diagnosis of diabetes mellitus requiring insulin therapy or metabolism alteration were excluded from the
analysis. Patients were divided into “insulin resistant” and “non-insulin resistant” based on the Homeostasis Model
Assessment index (HOMA IR). Results are expressed as medians.
Results: Out of 175 trauma patients admitted to the ICU during the study period, a total of 54 patients without
head trauma were considered for the study, 37 of whom met the inclusion criteria. In total, 23 patients (62.2%)
resulted insulin resistant, whereas 14 patients (37.8%) were non-insulin resistant. Groups were comparable in
demographic, clinical/laboratory characteristics, and severity of injury. Insulin resistant patients had a significantly
higher BMI (P=0.0416), C-reactive protein (P=0.0265), and leukocytes count (0.0301), compared to non-insulin
resistant patients. Also ICU length of stay was longer in insulin resistant patients (P=0.0381).
Conclusions: Our data suggest that admission insulin resistance might be used as an early outcome predictor.
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Hyperglycemia following major trauma is a well know
phenomenon related to stress-induced systemic reaction
[1]. Despite the recognized importance of glucose con-
trol, in major trauma with head injury, strict glucose
control might be not appropriate since the risk of
hypoglycemia (even transient) is as dangerous as uncon-
trolled hyperglycemia for the injured brain [2]. In this
context, studies available cannot clarify if early hypergly-
cemia, such as epiphenomena of stress-induced insulin
resistance, can be considered an outcome parameter in* Correspondence: giovanni.zagli@unifi.it
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reproduction in any medium, provided the orpolitrauma without head injury, in which strict glucose
control can be done more properly. Little data is avail-
able on the prognostic role of acute insulin-resistance in
trauma patients in absence of head injury.
The aim of this study was therefore to investigate the
prognostic role of acute insulin-resistance, as assessed
by the Homeostatic Model Assessment (HOMA index)
in patients with severe trauma without head injury.Methods
Patient selection and study design
This is a prospective, pilot study in which all patients
consecutively admitted to the ICU of a tertiary referral
center (Careggi Teaching Hospital, Florence, IT) for
major trauma without head injury from January toal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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from ICU databases and the Italian Group for the Evalu-
ation of Interventions in Intensive Care Medicine data-
base (GiViTI Margherita Project, Istituto Mario Negri,
Bergamo, Italy) were collected: age, gender, body mass
index (BMI), medical history, injury severity score (ISS),
simplified acute physiology score (SAPS) II, Sequential
Organ Failure Assessment (SOFA score), duration of
mechanical ventilation, ICU length of stay (LOS).
Past medical history was obtained through patient
interviews or from the families of those unable to be
interviewed. Patients with a previous diagnosis of dia-
betes mellitus requiring insulin therapy or alteration in
fat acid metabolism were excluded from the analysis.
The Internal Review Board approved of the study, and
informed consent for study participation and data publi-
cation was obtained from patients.
Definition of insulin resistance and outcome parameters
Criteria used for the definition of insulin resistance are
in accordance with the recently published guidelines
proposed by the European Group of the study of Insu-
lin Resistance (EGIR: www.egir.org). Patients were
divided into “insulin resistant” and “non-insulin resist-
ant” groups, based on the Homeostasis Model Assess-
ment – HOMA, calculated for each individual. Subjects
whose values exceeded the sex-specific 75th percentile
(i.e. 1.80 for women and 2.12 for men) were considered
to have insulin resistance (Homeostasis Model Assess-
ment - HOMA-IR) [3] [4] [5].
As primary outcome end points we considered ICU
mortality and ICU LOS. Secondary end points were days
of mechanical ventilation and infection (sum of pneu-
moniae and wound infection) rate.Table 1 Comparison of baseline and clinical characteristics in
non-insulin resistant patients
Overall Insu
Number,% (N) 37 62.2%
Age (years) 38.5 (29.8-60.3) 41.5
Male sex, N (%) 75.7% (28) 73.9%
BMI (Kg/m2) 24.7 (22.8-26.1) 25.7
SAPS II 31 (19–45) 33 (2
ISS 29 (22–36) 27 (2
SOFA score 6 (3–9) 7 (4.5
Infections during ICU stay,% (N) 46% (17) 52%
Duration of mechanical ventilation (days) 4 (1–11) 7 (1–
LOS ICU (days) 7 (3–16) 8 (4–
ICU mortality,% (N) 5% (2) 9% (
Continuous data are analysed with two-tail Student's t-test or Mann–Whitney test, a
expressed as medians with 25th to 75th interquartile range (IQR). Categorical variabl
AIS Abbreviated Injury Scale, BMI Body Mass Index ISS Injury Severity Score, ICU Inte
SOFA Sequential Organ Failure Assessment.Statistical analysis
Statistical analyses were carried out by SPSS 18 (SPSS
Inc., Chicago, Illinois). Continuous variables were ana-
lysed with two-tail Student's t-test or Mann–Whitney
test, as appropriate (D'Agostino & Pearson normality
test). Continuous variables are expressed as medians with
25th to 75th interquartile range (IQR). Categorical vari-
ables were examined using Fisher’s exact test. A P value
below 0.05 was considered an index of statistical signifi-
cance. Univariable comparison was reported as odds
ratio (OR) with 95% confidence intervals (CI).
A logistic regression model was adopted to investigate
the predictors of insulin resistance index in overall
population. Each predictor likely related to the outcome
was evaluated according to statistical and clinical bases.
Covariates associated with the response variables (p≤0.2)
in univariate analysis were retained in the multivariate
model (P<0.05).Results
Out of 175 trauma patients admitted to the ICU during
the whole study period, a total of 54 patients without
head trauma were considered for the study, 37 of
whom met the inclusion criteria and were therefore en-
rolled. Demographics and clinical characteristics are
shown in Table 1. According to HOMA index positiv-
ity, 23 patients were classified as “insulin resistant”,
whereas 14 patients were included in the non-insulin
resistant group. Groups resulted comparable in demo-
graphic characteristics and severity of trauma (ISS
score), however, they significantly differed in BMI (25.7
vs 23.5 Kg/m2, p=0.0416), and ICU LOS (8 vs 4.5 days,
p=0.0381) (Table 1).overall population, insulin resistant patients, and
lin resistant patients Non-insulin resistant patients P
(23) 37.8% (14)
(32.8-62.8) 37.5 (27.5-54.3) 0.3142
(17) 78.6% (11) 1.0000
(22.7-26.2) 23.5 (22.9-24.6) 0.0416
1.5-48) 19.5 (17–39.8) 0.1322
0.5-36) 29 (27–36) 0.5609
-10.5) 4 (3–7.5) 0.0957
(12) 36% (5) 1.0000
12) 2 (1–5) 0.2887
15) 4.5 (3–14) 0.0381
2) 0 1.0000
s appropriate (D'Agostino & Pearson normality test). Continuous variables are
es were examined using Fisher’s exact test. P significant if <0.05 (bold).
nsive Care Unit, LOS Length Of Stay, SAPS Simplified Acute Physiology Score,
Table 2 Comparison of laboratory data at ICU admission in overall population, insulin resistant patients, and
non-insulin resistant patients
Overall Insulin resistant patients Non-insulin resistant patients P
Number,% (N) 37 62.2% (23) 37.8% (14)
Leukocytes (n*1000/ml) 9.6 (7.9-13.1) 11.1 (9.1-3.7) 8.2 (7.8-9.5) 0.0301
Haemoglobin (gr/dl) 10.1 (9–11.4) 9.8 (9.2-11) 10.1 (9–11.9) 0.7441
Fibrinogen (mg/dl) 361 (317–525) 359 (313–527) 375 (345–490) 0.8413
Antithrombin III (%) 74 (64–87) 71 (65–86) 79 (62–88) 0.6885
D-dimers (μg/l) 3455 (2034–5960) 3655 (2591–5415) 3198 (1962–6387) 0.7398
Blood glucose (mmol/l) 7 (6.1-7.4) 7.2 (6.5-7.4) 6.3 (5.7-7.4) 0.1578
Plasma insulin (mU/l) 9.90 (4.78-19.48) 15.55 (11.10-24.08) 4.55 (3.23-5.48) <0.0001
HOMA index 3.20 (1.46-5.76) 4.72 (3.65-8.84) 1.27 (0.983-1.57) <0.0001
C-peptides (mmol/l) 0.72 (0.46-1.05) 0.95 (0.53-1.12) 0.43 (0.32-0.65) 0.0061
Glycated hemoglobin,% 5.4 (5.2-5.6) 5.5 (5.3-5.7) 5.4 (5.2-5.6) 0.2067
Total plasma proteins (g/dl) 4.80 (4.20-5.20) 4.7 (4.3-5.2) 4.8 (4.3-5.2) 0.9875
Plasma albumin (g/l) 25.70 (20.35-30.45) 25.7 (19.3-29.4) 26.1 (23.7-31.3) 0.4042
Arterial lactates (mmol/l) 1.15 (0.80-2) 1.2 (0.9-1.9) 1.3 (0.8-2) 0.8754
C-reactive protein (mg/l) 114 (74–165.5) 140.5 (90.8-197.8) 83 (70–97) 0.0265
Triglycerides (mg/dl) 77 (53–114) 88 (64–150) 57 (46–88) 0.2351
Total cholesterol (mg/dl) 106 (82–112) 108 (104–123) 83 (75–109) 0.0700
Cholesterol HDL (mg/dl) 26 (22–33) 26 (25–34) 24 (18–31) 0.2635
AST (U/l) 72 (35–165) 63 (38–169) 68 (34–155) 0.9388
ALT (U/l) 43 (28–122) 40 (28–69) 48 (30–154) 0.4659
CPK (U/l) 1556 (891–3531) 1336 (696–4228) 2040 (1149–3215) 0.5702
LDH (U/l) 537 (240–500) 297 (237–495) 391 (345–507) 0.1670
Myoglobin (ng/ml) 993 (340–1824) 762 (351–2475) 1316 (314–1574) 0.3185
Continuous data are analysed with two-tail Student's t-test or Mann–Whitney test, as appropriate (D'Agostino & Pearson normality test). Continuous variables are
expressed as medians with 25th to 75th interquartile range (IQR). P significant if <0.05 (bold).
ALT alanine aminotransferase, AST aspartate aminotransferase, CPK creatine phosphokinase, HOMA Homeostasis Model Assessment, LDH lactate dehydrogenase,
NT-pro-BNP N-terminal-pro-brain natriuretic peptide.
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sion. Insulin-resistant patients resulted as having a sig-
nificantly higher C-reactive protein (140.5 vs 83,
p=0.0265, respectively) and leukocytes count (11,100 vs
8,200 cells/ml, p=0.0301, respectively) than non-insulin
resistant patients. Also, C-peptides were significantly
higher in insulin resistant patients (0.95 vs 0.43,
p=0.0061), whereas glycated hemoglobin resulted com-
parable between the groups (Table 2). The subsequent
logistic regression model did not show significant correl-
ation among variables and outcome parameters.
Discussion
The present investigation, to our knowledge, represents
the first study concerning the prognostic role of admis-
sion insulin resistance in trauma patients as a potential
tool for a better early risk stratification in these patients.
The main finding in 37 patients with major trauma
without head injury and without previously known dia-
betes is that admission acute insulin resistance (as
assessed by means of the HOMA model) is a common
finding, and it is associated with a longer ICU stay.Blood glucose levels were similar between the groups
thanks to the higher insulin secretion in insulin-resistant
patients: this phenomenon, in our opinion, merits fur-
ther analysing since the role of glucose control in critic-
ally ill patients is usually considered only in the case of
normal glycaemia. Our data, despite all limitations, sug-
gest that even higher insulin secretion can have a role in
organ dysfunction following major trauma.
Insulin resistance was significantly associated with a
longer ICU LOS (8 vs 4.5 days, p=0.0381; Table 1), but
we failed to verify the correlation with mortality, ventila-
tion days, and infection rate. Moreover, insulin resistant
patients differed (without reaching statistical signifi-
cance) from non-insulin resistant patients also in SAPS
II score (33 vs 19.5, respectively), SOFA score (7 vs 4, re-
spectively), infections during ICU stay (52% vs 36%, re-
spectively), and duration of mechanical ventilation (7 vs
2 days, respectively) (Table 1). The lack of statistical sig-
nificance might be attributed to the limited sample size
of the study, which can be considered the main limita-
tion of our work. Other important limitation factors are
the non-randomized and monocentric design of the
Bonizzoli et al. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2012, 20:69 Page 4 of 5
http://www.sjtrem.com/content/20/1/69study. Nevertheless, despite these limitations, the possi-
bility that admission HOMA-IR could be a predictive
factor in major trauma without head injury is very
intriguing.
Despite many studies on hyperglycaemia, very little
data is available on acute insulin resistance and its effect
on trauma patients’ outcome. Laird and co-authors [6]
showed in 2004 that hyperglycemia (defined as glucose
level >200 mg/dl, or >11 mmol/l) in trauma patients at
admission was associated with significantly higher infec-
tion and mortality rates. Even a mild admission hyper-
glycemia (>150 mg/dl, or >8.3 mmol/l) was recognised
as an independent predictor for mortality, postoperative
infection, and hospital and Intensive Care Unit (ICU)
length of stay [7] [8]. Bochicchio and co-workers
reported that critically ill trauma patients with a persist-
ent high glucose level (>140 mg/dl, or >7.8 mmol/l) had
a statistically significant ICU and hospital length of stay,
as well as mortality, even after adjusting for age and In-
jury Severity Score (ISS) [9]. Yendamuri and co-authors
showed in 2003 that even mild hyperglycemia
(>7.5 mmol/l) was a prognostic factor in an overall
trauma population, and not only in brain injured
patients [7]. More recently, Mowery and co-authors ana-
lysed insulin resistance in a wide range of traumatic
brain injured patients finding that insulin resistance was
a prognostic factor independent from strict glucose con-
trol [10], but the opportunity to perform strict glucose
control in traumatic brain injured patients remains ques-
tionable, since the effect of hypoglycemic episodes are
considered as dangerous as hyperglycemia [2]. Despite
numerous studies on glucose metabolism in traumatic
brain injured patients or in overall trauma populations,
as mentioned, very little data is available on insulin re-
sistance in major trauma patients without brain injury.
In our sample, the fact that hyperglycemia (secondary to
insulin resistance) might have significance as a prognos-
tic factor could make it possible to easily perform the
appropriate intervention, since the absence of brain in-
jury permits more aggressive glucose control.
In our study population, stress reaction following
major trauma without head injury caused secondary in-
sulin resistance in 62.2% of patients. The definition of
“secondary” came from the inclusion criteria (patients
with history of glucose metabolism alteration were
excluded) and from the confirmation of glycated
hemoglobin dosage, which resulted as comparable be-
tween groups (Table 2). The development of insulin re-
sistance can be related to post-traumatic systemic
inflammation, even considering the higher leukocytes
count and C-reactive protein dosage in insulin resistant
patients. Our finding is in agreement with data reported
in experimental rat models, in which it has been
observed that trauma alone results in modest insulinresistance, occurring gradually [11,12]. However, when
injury is combined with haemorrhage, a disorder in glu-
cose metabolism rapidly develops, occurring in rat liver
as soon as 15 min following trauma and haemorrhage.
This is characterized by severe defects in hepatic insulin
signalling, hyperinsulinemia and hyperglycemia [12-16].
Conclusions
In the present single-centre investigation, we found
that a large proportion of patients with major trauma
but no (or without) head injury developed insulin re-
sistance after accident as a result of systemic stress re-
action. It might be interesting to be reproducing this
phenomenon, associated with a longer ICU stay in our
population, in other centres and in larger populations,
with the aim to understand if early insulin-resistance
could be included in prognostic scoring.
Key messages
 Acute insulin resistance has been found to be
common in severe trauma without head injury and
without glucose metabolism alterations.
 Insulin resistance seems to be linked with acute
stress reaction.
 The develop of insulin resistance results to be a
predictor of ICU length of stay.
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